PCI BIOTECH HLD
PCI BIOTECH HLD operates in Diversified Metals & Mining.
PCI BIOTECH HLD (4QG) - Total Liabilities
Latest total liabilities as of June 2023: €5.61 Million EUR
Based on the latest financial reports, PCI BIOTECH HLD (4QG) has total liabilities worth €5.61 Million EUR as of June 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PCI BIOTECH HLD - Total Liabilities Trend (2016–2023)
This chart illustrates how PCI BIOTECH HLD's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PCI BIOTECH HLD Competitors by Total Liabilities
The table below lists competitors of PCI BIOTECH HLD ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BATERO GOLD (68B.SG)
STU:68B
|
Germany | €1.18 Million |
|
Present24 SA
WAR:P24
|
Poland | zł64.76K |
|
INM
WAR:INM
|
Poland | zł34.75 Million |
|
MEDIGENE N (MDG1.SG)
STU:MDG1
|
Germany | €9.15 Million |
|
DG Innovate PLC
LSE:DGI
|
UK | GBX3.12 Million |
|
IRPC PCL
STU:TPIG
|
Germany | €111.08 Billion |
Liability Composition Analysis (2016–2023)
This chart breaks down PCI BIOTECH HLD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PCI BIOTECH HLD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PCI BIOTECH HLD (2016–2023)
The table below shows the annual total liabilities of PCI BIOTECH HLD from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €5.01 Million | -17.63% |
| 2022-12-31 | €6.08 Million | -72.60% |
| 2021-12-31 | €22.19 Million | +11.61% |
| 2020-12-31 | €19.88 Million | -26.93% |
| 2019-12-31 | €27.20 Million | +59.07% |
| 2018-12-31 | €17.10 Million | +3.06% |
| 2017-12-31 | €16.59 Million | +78.20% |
| 2016-12-31 | €9.31 Million | -- |